Federated Hermes Portfolio holdings
AUM
$69.6B
Turnover
16.03%
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
5.4
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1351
Constellation Brands
STZ
$21.6B
| $461K | ﹤0.01% |
2,834
-1,286
| -31% | -$231K |
2013 Q2
48 quarters
|
|
1352
Assembly Biosciences
ASMB
$418M
| $460K | ﹤0.01% |
25,394
| – | – |
2021 Q1
17 quarters
|
|
1353
Landstar System
LSTR
$5.74B
| $458K | ﹤0.01% |
3,295
-960
| -23% | -$133K |
2013 Q2
48 quarters
|
|
1354
Scorpio Tankers
STNG
$4.31B
| $451K | ﹤0.01% |
11,530
+2,287
| +25% | +$89.2K |
2022 Q2
12 quarters
|
|
1355
Ormat Technologies
ORA
$5.42B
| $451K | ﹤0.01% |
5,380
-62
| -1% | -$4.63K |
2022 Q3
11 quarters
|
|
1356
Thor Industries
THO
$3.38B
| $449K | ﹤0.01% |
5,061
-1,973
| -28% | -$156K |
2013 Q2
48 quarters
|
|
1357
Valvoline
VVV
$3.88B
| $449K | ﹤0.01% |
11,866
-169
| -1% | -$5.91K |
2017 Q1
33 quarters
|
|
1358
Ubiquiti
UI
$36.7B
| $449K | ﹤0.01% |
1,091
-211
| -16% | -$76.8K |
2025 Q1
1 quarter
|
|
1359
NexPoint Residential Trust
NXRT
$467M
| $445K | ﹤0.01% |
13,355
+845
| +7% | +$29.9K |
2021 Q2
16 quarters
|
|
1360
MGM Resorts International
MGM
$7.29B
| $444K | ﹤0.01% |
12,918
-1,243
| -9% | -$39.4K |
2016 Q3
35 quarters
|
|
1361
Amphenol
APH
$204B
| $443K | ﹤0.01% |
8,976
-148,346
| -94% | -$6.07M |
2013 Q2
48 quarters
|
|
1362
Ennis
EBF
$566M
| $442K | ﹤0.01% |
24,388
-419
| -2% | -$7.85K |
2015 Q1
41 quarters
|
|
1363
Asana
ASAN
$2.25B
| $442K | ﹤0.01% |
32,748
+17
| +0.1% | +$266 |
2025 Q1
1 quarter
|
|
1364
New Jersey Resources
NJR
$5.26B
| $438K | ﹤0.01% |
9,764
-329
| -3% | -$15.4K |
2013 Q3
47 quarters
|
|
1365
NOV
NOV
$6.68B
| $436K | ﹤0.01% |
35,076
-984
| -3% | -$12.4K |
2021 Q1
17 quarters
|
|
1366
Novanta
NOVT
$5.3B
| $433K | ﹤0.01% |
3,358
-43
| -1% | -$5.23K |
2017 Q2
32 quarters
|
|
1367
Quaker Houghton
KWR
$2.73B
| $433K | ﹤0.01% |
+3,865
| New | +$420K |
2025 Q2
0 quarters
|
|
1368
Gentherm
THRM
$1.67B
| $431K | ﹤0.01% |
+15,244
| New | +$405K |
2025 Q2
0 quarters
|
|
1369
Timken Company
TKR
$7.78B
| $431K | ﹤0.01% |
5,943
-99
| -2% | -$6.73K |
2013 Q2
48 quarters
|
|
1370
Graham Holdings Company
GHC
$5.02B
| $431K | ﹤0.01% |
455
+136
| +43% | +$128K |
2013 Q2
48 quarters
|
|
1371
Ingevity
NGVT
$2.41B
| $429K | ﹤0.01% |
9,952
-11,187
| -53% | -$432K |
2024 Q2
4 quarters
|
|
1372
Bruker
BRKR
$8.47B
| $425K | ﹤0.01% |
10,326
-153
| -1% | -$5.91K |
2013 Q4
46 quarters
|
|
1373
Sabra Healthcare REIT
SBRA
$4.9B
| $425K | ﹤0.01% |
23,070
-643
| -3% | -$11.4K |
2016 Q3
35 quarters
|
|
1374
Hexcel
HXL
$6.64B
| $424K | ﹤0.01% |
7,507
-175
| -2% | -$9.25K |
2020 Q1
21 quarters
|
|
1375
Essex Property Trust
ESS
$17.3B
| $423K | ﹤0.01% |
1,494
-368
| -20% | -$103K |
2013 Q2
48 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.